Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.
Gennari
C
C
Institute of Internal Medicine, University of Siena, Italy.
Agnusdei
D
D
Camporeale
A
A
D000281:Administration, Intranasal; D000328:Adult; D000336:Aerosols; D015519:Bone Density / Q000187:drug effects*; D001842:Bone and Bones / Q000378:metabolism*; D002116:Calcitonin / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D008875:Middle Aged; D015675:Osteocalcin / Q000097:blood; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000378:metabolism; D013997:Time Factors
D000336:Aerosols; D015675:Osteocalcin; C028815:salmon calcitonin; D002116:Calcitonin; D006909:Hydroxyproline